• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与代谢综合征在结肠镜检查结直肠肿瘤方面的关系。

The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.

作者信息

Pan Shuang, Hong Wandong, Wu Wenzhi, Chen Qinfen, Zhao Qian, Wu Jiansheng, Jin Yin

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

出版信息

Medicine (Baltimore). 2017 Jan;96(2):e5809. doi: 10.1097/MD.0000000000005809.

DOI:10.1097/MD.0000000000005809
PMID:28079806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5266168/
Abstract

Colorectal neoplasm is considered to have a strong association with nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS), respectively. The relationship among NAFLD, MetS, and colorectal neoplasm was assessed in 1793 participants. Participants were divided into 4 groups based on the status of NAFLD and MetS. Relative excess risks of interaction (RERI), attributable proportion (AP), and synergy index (SI) were applied to evaluate the additive interaction. NAFLD and MetS were significantly correlated with colorectal neoplasm and colorectal cancer (CRC), respectively. The incidence of CRC in NAFLD (+) MetS (+) group was significantly higher than other 3 groups. The result of RERI, AP, and SI indicated the significant additive interaction of NAFLD and MetS on the development of CRC. NAFLD and MetS are risk factors for colorectal neoplasm and CRC, respectively. And NAFLD and MetS have an additive effect on the development of CRC.

摘要

结直肠肿瘤被认为分别与非酒精性脂肪性肝病(NAFLD)和代谢综合征(MetS)密切相关。在1793名参与者中评估了NAFLD、MetS和结直肠肿瘤之间的关系。参与者根据NAFLD和MetS的状况分为4组。采用交互作用的相对超额风险(RERI)、归因比例(AP)和协同指数(SI)来评估相加交互作用。NAFLD和MetS分别与结直肠肿瘤和结直肠癌(CRC)显著相关。NAFLD(+)MetS(+)组的CRC发病率显著高于其他3组。RERI、AP和SI的结果表明NAFLD和MetS在CRC发生发展中存在显著的相加交互作用。NAFLD和MetS分别是结直肠肿瘤和CRC的危险因素。并且NAFLD和MetS在CRC发生发展中具有相加作用。

相似文献

1
The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.非酒精性脂肪性肝病与代谢综合征在结肠镜检查结直肠肿瘤方面的关系。
Medicine (Baltimore). 2017 Jan;96(2):e5809. doi: 10.1097/MD.0000000000005809.
2
Non-alcoholic fatty liver disease and colorectal cancer.非酒精性脂肪性肝病与结直肠癌
Postgrad Med J. 2017 Mar;93(1097):153-158. doi: 10.1136/postgradmedj-2016-134383. Epub 2016 Nov 16.
3
The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.非酒精性脂肪性肝病和代谢综合征对中国女性结直肠癌死亡率的综合影响:一项回顾性研究。
World J Surg Oncol. 2018 Aug 10;16(1):163. doi: 10.1186/s12957-018-1461-z.
4
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.非酒精性脂肪性肝病伴或不伴代谢综合征:不同的长期转归。
Metabolism. 2017 Jan;66:55-63. doi: 10.1016/j.metabol.2016.06.009. Epub 2016 Jul 1.
5
Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy.非酒精性脂肪性肝病患者在基线结肠镜检查阴性后结直肠腺瘤风险增加。
Colorectal Dis. 2013 Jul;15(7):830-5. doi: 10.1111/codi.12172.
6
Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.非酒精性脂肪肝与无症状成人筛查性结肠镜检查中结直肠肿瘤的相关性:系统评价和荟萃分析。
Metabolism. 2018 Oct;87:1-12. doi: 10.1016/j.metabol.2018.06.004. Epub 2018 Jun 20.
7
Screening strategies for colorectal cancer among patients with nonalcoholic fatty liver disease and family history.非酒精性脂肪性肝病患者及有家族史人群的结直肠癌筛查策略
Int J Cancer. 2016 Feb 1;138(3):576-83. doi: 10.1002/ijc.29809. Epub 2015 Sep 1.
8
Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.非酒精性脂肪性肝病对结直肠肿瘤发生的临床影响:倾向评分匹配分析
PLoS One. 2017 Aug 4;12(8):e0182014. doi: 10.1371/journal.pone.0182014. eCollection 2017.
9
Association of nonalcoholic fatty liver disease and liver cancer.非酒精性脂肪性肝病与肝癌的关联
World J Gastroenterol. 2015 Jan 21;21(3):913-8. doi: 10.3748/wjg.v21.i3.913.
10
Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的饮食摄入与代谢综合征存在情况之间的关联。
J Hum Nutr Diet. 2015 Aug;28(4):409-15. doi: 10.1111/jhn.12323. Epub 2015 May 19.

引用本文的文献

1
Novel non-HDLc/HDLc ratio for predicting MASLD: a cross-sectional study in a Chinese health screening population.新型非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值预测代谢相关脂肪性肝病:中国健康体检人群的横断面研究。
BMC Gastroenterol. 2024 Nov 28;24(1):439. doi: 10.1186/s12876-024-03525-z.
2
Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的肝外恶性肿瘤
Curr Hepatol Rep. 2019 Dec;18(4):455-472. doi: 10.1007/s11901-019-00499-5. Epub 2019 Nov 15.
3
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep's Clothing?非酒精性脂肪性肝病与肝外癌症:披着羊皮的狼?
Curr Oncol. 2022 Jun 25;29(7):4478-4510. doi: 10.3390/curroncol29070356.
4
Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study.非酒精性脂肪性肝病患者的肝内和肝外癌症风险:一项基于人群的队列研究。
Liver Int. 2022 Apr;42(4):820-828. doi: 10.1111/liv.15195. Epub 2022 Feb 24.
5
Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions.非酒精性脂肪性肝病:关注新的生物标志物和生活方式干预。
Int J Mol Sci. 2021 Apr 9;22(8):3899. doi: 10.3390/ijms22083899.
6
The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.非酒精性脂肪性肝病与心血管疾病、中风及肝外癌症风险之间的关联
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):45-81. doi: 10.1016/j.jceh.2020.04.018. Epub 2020 May 20.
7
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review.非酒精性脂肪性肝病作为人类的一种代谢性疾病:文献综述。
Diabetes Obes Metab. 2021 May;23(5):1069-1083. doi: 10.1111/dom.14322. Epub 2021 Feb 10.
8
Value of routine test for identifying colorectal cancer from patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者常规检测用于结直肠癌筛查的价值。
BMC Gastroenterol. 2020 Jun 9;20(1):180. doi: 10.1186/s12876-020-01327-7.
9
Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.非酒精性脂肪性肝病与肝外癌症的相关性:系统评价和荟萃分析。
Lipids Health Dis. 2020 May 31;19(1):118. doi: 10.1186/s12944-020-01288-6.
10
The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.非酒精性脂肪性肝病和代谢综合征对中国女性结直肠癌死亡率的综合影响:一项回顾性研究。
World J Surg Oncol. 2018 Aug 10;16(1):163. doi: 10.1186/s12957-018-1461-z.

本文引用的文献

1
Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?良性前列腺增生、代谢综合征与非酒精性脂肪性肝病:代谢性炎症是其中的联系吗?
Prostate. 2016 Dec;76(16):1528-1535. doi: 10.1002/pros.23237. Epub 2016 Jul 25.
2
The association between comorbidities and the quality of life among colorectal cancer survivors in the People's Republic of China.中华人民共和国结直肠癌幸存者的合并症与生活质量之间的关联。
Patient Prefer Adherence. 2016 Jun 14;10:1071-7. doi: 10.2147/PPA.S100873. eCollection 2016.
3
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome.非酒精性脂肪性肝病与代谢综合征特征之间的双向关系及脱节
Int J Mol Sci. 2016 Mar 11;17(3):367. doi: 10.3390/ijms17030367.
4
Colorectal Cancer Mortality Characteristics and Predictions in China, 1991-2011.1991 - 2011年中国结直肠癌死亡率特征及预测
Asian Pac J Cancer Prev. 2015;16(17):7991-5. doi: 10.7314/apjcp.2015.16.17.7991.
5
The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis.非酒精性脂肪性肝病与代谢综合征对亚临床动脉粥样硬化的协同影响。
Clin Endocrinol (Oxf). 2016 Feb;84(2):203-209. doi: 10.1111/cen.12940. Epub 2015 Oct 9.
6
Targeting inflammation in metabolic syndrome.针对代谢综合征中的炎症
Transl Res. 2016 Jan;167(1):257-80. doi: 10.1016/j.trsl.2015.06.017. Epub 2015 Jul 3.
7
Metabolic syndrome and colorectal neoplasms: An ominous association.代谢综合征与结直肠肿瘤:一种不祥的关联。
World J Gastroenterol. 2015 May 7;21(17):5320-7. doi: 10.3748/wjg.v21.i17.5320.
8
Association of liver steatosis with colorectal cancer and adenoma in patients with metabolic syndrome.代谢综合征患者中肝脂肪变性与结直肠癌和腺瘤的关联。
Anticancer Res. 2015 Apr;35(4):2211-4.
9
Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study.非酒精性脂肪性肝病患者患结直肠恶性肿瘤的风险增加:一项大型研究。
Mol Biol Rep. 2014 May;41(5):2989-97. doi: 10.1007/s11033-014-3157-y. Epub 2014 Jan 22.
10
PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.PNPLA3基因多态性导致无代谢综合征的社区人群出现脂肪肝。
Aliment Pharmacol Ther. 2014 Mar;39(5):532-9. doi: 10.1111/apt.12609. Epub 2014 Jan 13.